All In Biotech

Drug Trial Radar · NCT04608630

Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults - A Randomised Controlled Trial

Last checked: Nov 20, 2026Latest source record: Mar 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Jul 15, 2021

Primary completion

Feb 28, 2027

Study completion Feb 28, 2027

Sponsor

Lead sponsor
Australian and New Zealand Intensive Care Research CentreAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 29, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Bone Zone trial is a prospective, multi-centre, double-blind, phase II, randomised controlled trial evaluating the effect of denosumab or zoledronic acid compared to placebo on change in bone mineral density over one year in women aged 50 years or older and men aged 70 years or older requiring admission to intensive care for greater than 24 hours. 450 women aged 50 years or older and men aged 70 years or older, admitted to intensive care for greater than 24 hours will be recruited into the study from participating study centres.

Conditions

  • Critical Illness
  • Osteoporosis

Interventions

  • Denosumab 60 MG/MLDrug

    Patients allocated to the Denosumab arm will receive Denosumab 60mg in 1ml, administered via subcutaneous injection on Study Days 1 and 180.

  • Zoledronic Acid 5Mg/Bag 100Ml InjDrug

    Patients allocated to the Zoledronic acid arm will receive Zoledronic acid 5mg in 100ml 0.9% Sodium Chloride or 5% Dextrose, administered via intravenous infusion over at least 15 minutes on Study Day 1.

  • Sodium Chloride 0.9% or 5% Dextrose IntravenousDrug

    Patients allocated to the placebo arm and Denosumab arm will receive 0.9% Sodium Chloride or 5% Dextrose 100ml administered via intravenous infusion over at least 15 minutes on Day 1.

  • Sodium Chloride 0.9% InjectionDrug

    Patients allocated to the placebo arm and Zoledronic acid arm will receive 0.9% Sodium Chloride 1ml administered via subcutaneous injection on Days 1 and Day 180

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualised change in femoral neck bone mineral density for the year after Intensive Care dischargeTime frame: 12 months

Locations

22 sites in 2 countries. Site status is shown where the registry gives one.

  • St Vincent's Health Sydney

    Sydney, New South Wales, Australia · Recruiting

  • Prince of Wales Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Blacktown Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Royal Prince Alfred Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Wollongong Hospital, Illawarra Shoalhaven Health

    Wollongong, New South Wales, Australia · Recruiting

  • Sunshine Coast University Hospital

    Birtinya, Queensland, Australia · Recruiting

  • The Wesley Hospital

    Brisbane, Queensland, Australia · Recruiting

  • Gold Coast University Hospital

    Southport, Queensland, Australia · Recruiting

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Barwon Health, University Hospital Geelong

    Geelong, Victoria, Australia · Recruiting

  • Alfred Health

    Melbourne, Victoria, Australia · Completed

  • Western Health - Footscray Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Western Health - Sunshine Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia · Recruiting

  • St Vincents Hospital Melbourne

    Melbourne, Victoria, Australia · Recruiting

  • Austin Health

    Melbourne, Victoria, Australia · Completed

  • Eastern Health - Box Hill Hospital

    Melbourne, Victoria, Australia · Recruiting

  • St John of God Hospital Subiaco

    Perth, Western Australia, Australia · Recruiting

  • Fiona Stanley Hospital

    Perth, Western Australia, Australia · Recruiting

  • St John of God Hospital Murdoch

    Perth, Western Australia, Australia · Recruiting

  • Auckland City Hospital

    Auckland, New Zealand · Recruiting

  • Wellington Regional Hospital

    Wellington, New Zealand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.